Summary

The global Point of Care (POC) Diagnostics Market is poised for steady growth, driven by the increasing demand for rapid and accurate diagnostic solutions. Point of care diagnostics enable healthcare providers to conduct tests near the patient, delivering immediate results and enhancing clinical decision-making. With rising prevalence of chronic diseases, infectious conditions, and a growing focus on preventive healthcare, the market is projected to reach USD 15.3 billion in 2026 and expand to USD 20.3 billion by 2033, registering a CAGR of 4.1% during the forecast period.



Point of care testing offers a unique advantage by reducing the time between diagnosis and treatment, improving patient outcomes, and minimizing hospital stays. The integration of advanced technologies, including biosensors, microfluidics, and wireless connectivity, is further enhancing the efficiency and accuracy of these diagnostic tools.



Market Insights



The Point of Care Diagnostics Market is characterized by rapid technological innovation and growing consumer preference for convenient healthcare solutions. Blood glucose monitoring remains a dominant segment, driven by the increasing prevalence of diabetes worldwide. Infectious disease testing, particularly for conditions such as COVID-19, influenza, and sexually transmitted infections, has witnessed unprecedented growth in recent years, highlighting the importance of rapid diagnostics.



The market is also witnessing significant growth in cardiometabolic disease testing, pregnancy and fertility testing, and hematology testing. Home-based testing solutions are increasingly gaining popularity, enabling patients to monitor their health in real time without frequent hospital visits. Additionally, the use of point of care diagnostics in physician offices, urgent care centers, and retail clinics is rising, reflecting the shift toward decentralized healthcare delivery.



Market Drivers



Several factors are driving the expansion of the Point of Care Diagnostics Market. The increasing prevalence of chronic and lifestyle-related diseases, such as diabetes, cardiovascular diseases, and obesity, is fueling demand for rapid and accurate monitoring tools. The ongoing COVID-19 pandemic has further emphasized the need for quick and decentralized diagnostic solutions, increasing investments in POC testing infrastructure.



Technological advancements, including miniaturization of diagnostic devices, integration of artificial intelligence, and connectivity with mobile applications, are enhancing the ease of use and accuracy of point of care tests. Moreover, the rising awareness among patients and healthcare providers about the benefits of early diagnosis and timely intervention is supporting market growth.



Business Opportunity



The Point of Care Diagnostics Market presents significant business opportunities for manufacturers, healthcare providers, and technology innovators. Companies focusing on portable and user-friendly diagnostic devices can capitalize on the growing demand for home testing solutions. Strategic partnerships between diagnostic device manufacturers and healthcare institutions can drive adoption in hospitals, physician offices, and urgent care centers.



Emerging markets offer substantial growth potential due to increasing healthcare expenditure, government initiatives to improve access to diagnostics, and the rising prevalence of infectious and chronic diseases. Companies investing in innovative solutions that combine rapid diagnostics with digital health technologies are likely to gain a competitive edge in the market.



Regional Analysis



North America holds a significant share of the global Point of Care Diagnostics Market, driven by high adoption of advanced healthcare technologies, well-established healthcare infrastructure, and favorable reimbursement policies. The United States, in particular, remains a key market for blood glucose monitoring and infectious disease testing.



Europe is witnessing steady growth due to increasing awareness of preventive healthcare and rising demand for rapid diagnostics across hospitals and outpatient care settings. Germany, the United Kingdom, and France are leading markets in the region.



The Asia Pacific region is expected to register the highest growth rate during the forecast period, fueled by rising healthcare expenditure, expanding diagnostic infrastructure, and growing prevalence of chronic and infectious diseases. China, India, and Japan are major contributors to market growth in this region.



Latin America is gradually adopting point of care diagnostics, driven by government initiatives to improve access to healthcare services. Similarly, the Middle East and Africa region is experiencing growing demand for rapid diagnostic solutions, especially in response to infectious disease outbreaks and increasing investment in healthcare infrastructure.



Key Players



The global Point of Care Diagnostics Market is highly competitive, with several multinational companies and emerging players focusing on technological innovation and strategic collaborations. Key players in the market include



• Abbott Laboratories



• Roche Diagnostics



• Siemens Healthineers



• Danaher Corporation (including Beckman Coulter & Cepheid)



• Thermo Fisher Scientific



• QuidelOrtho Corporation



• Becton, Dickinson and Company (BD)



• bioMérieux



• Hologic, Inc.



• Nova Biomedical



• LumiraDx



• OraSure Technologies



• Fujirebio Inc.



• Siemens AG (POC division)



• Sekisui Diagnostics



Market Segmentation



By Product



• Blood Glucose Monitoring



• Infectious Disease Testing



• Cardiometabolic Disease Testing



• Pregnancy & Fertility Testing



• Hematology Testing



• Others



By Sample



• Blood



• Nasal and Oropharyngeal Swabs



• Urine



• Others



By End-User



• Hospital Bedside



• Physician’s Office Lab



• Urgent Care & Retail Clinics



• Home & Self Testing



By Region



• North America



• Europe



• Asia Pacific



• Latin America



• Middle East & Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Point Of Care Diagnostics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Fiver Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Point Of Care Diagnostics Market Outlook, 2020-2033
3.1. Global Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
3.1.1. Blood Glucose Monitoring
3.1.2. Infectious Disease Testing
3.1.3. Cardiometabolic Disease Testing
3.1.4. Pregnancy & Fertility Testing
3.1.5. Hematology Testing
3.1.6. Others
3.2. Global Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
3.2.1. Blood
3.2.2. Nasal and Oropharyngeal Swabs
3.2.3. Urine
3.2.4. Others
3.3. Global Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
3.3.1. Hospital Bedside
3.3.2. Physician’s Office Lab
3.3.3. Urgent Care & Retail Clinics
3.3.4. Home & Self Testing
3.4. Global Point Of Care Diagnostics Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Point Of Care Diagnostics Market Outlook, 2020-2033
4.1. North America Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
4.1.1. Blood Glucose Monitoring
4.1.2. Infectious Disease Testing
4.1.3. Cardiometabolic Disease Testing
4.1.4. Pregnancy & Fertility Testing
4.1.5. Hematology Testing
4.1.6. Others
4.2. North America Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
4.2.1. Blood
4.2.2. Nasal and Oropharyngeal Swabs
4.2.3. Urine
4.2.4. Others
4.3. North America Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
4.3.1. Hospital Bedside
4.3.2. Physician’s Office Lab
4.3.3. Urgent Care & Retail Clinics
4.3.4. Home & Self Testing
4.4. North America Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
4.4.2. U.S. Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
4.4.3. U.S. Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
4.4.4. Canada Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
4.4.5. Canada Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
4.4.6. Canada Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Point Of Care Diagnostics Market Outlook, 2020-2033
5.1. Europe Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
5.1.1. Blood Glucose Monitoring
5.1.2. Infectious Disease Testing
5.1.3. Cardiometabolic Disease Testing
5.1.4. Pregnancy & Fertility Testing
5.1.5. Hematology Testing
5.1.6. Others
5.2. Europe Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
5.2.1. Blood
5.2.2. Nasal and Oropharyngeal Swabs
5.2.3. Urine
5.2.4. Others
5.3. Europe Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
5.3.1. Hospital Bedside
5.3.2. Physician’s Office Lab
5.3.3. Urgent Care & Retail Clinics
5.3.4. Home & Self Testing
5.4. Europe Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
5.4.2. Germany Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
5.4.3. Germany Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
5.4.4. Italy Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
5.4.5. Italy Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
5.4.6. Italy Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
5.4.7. France Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
5.4.8. France Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
5.4.9. France Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
5.4.10. U.K. Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
5.4.11. U.K. Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
5.4.12. U.K. Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
5.4.13. Spain Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
5.4.14. Spain Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
5.4.15. Spain Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
5.4.16. Russia Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
5.4.17. Russia Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
5.4.18. Russia Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
5.4.19. Rest of Europe Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
5.4.20. Rest of Europe Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
5.4.21. Rest of Europe Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Point Of Care Diagnostics Market Outlook, 2020-2033
6.1. Asia Pacific Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
6.1.1. Blood Glucose Monitoring
6.1.2. Infectious Disease Testing
6.1.3. Cardiometabolic Disease Testing
6.1.4. Pregnancy & Fertility Testing
6.1.5. Hematology Testing
6.1.6. Others
6.2. Asia Pacific Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
6.2.1. Blood
6.2.2. Nasal and Oropharyngeal Swabs
6.2.3. Urine
6.2.4. Others
6.3. Asia Pacific Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
6.3.1. Hospital Bedside
6.3.2. Physician’s Office Lab
6.3.3. Urgent Care & Retail Clinics
6.3.4. Home & Self Testing
6.4. Asia Pacific Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
6.4.2. China Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
6.4.3. China Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
6.4.4. Japan Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
6.4.5. Japan Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
6.4.6. Japan Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
6.4.7. South Korea Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
6.4.8. South Korea Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
6.4.9. South Korea Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
6.4.10. India Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
6.4.11. India Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
6.4.12. India Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
6.4.13. Southeast Asia Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
6.4.14. Southeast Asia Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
6.4.15. Southeast Asia Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
6.4.16. Rest of SAO Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
6.4.17. Rest of SAO Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
6.4.18. Rest of SAO Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Point Of Care Diagnostics Market Outlook, 2020-2033
7.1. Latin America Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
7.1.1. Blood Glucose Monitoring
7.1.2. Infectious Disease Testing
7.1.3. Cardiometabolic Disease Testing
7.1.4. Pregnancy & Fertility Testing
7.1.5. Hematology Testing
7.1.6. Others
7.2. Latin America Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
7.2.1. Blood
7.2.2. Nasal and Oropharyngeal Swabs
7.2.3. Urine
7.2.4. Others
7.3. Latin America Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
7.3.1. Hospital Bedside
7.3.2. Physician’s Office Lab
7.3.3. Urgent Care & Retail Clinics
7.3.4. Home & Self Testing
7.4. Latin America Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
7.4.2. Brazil Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
7.4.3. Brazil Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
7.4.4. Mexico Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
7.4.5. Mexico Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
7.4.6. Mexico Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
7.4.7. Argentina Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
7.4.8. Argentina Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
7.4.9. Argentina Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
7.4.10. Rest of LATAM Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
7.4.11. Rest of LATAM Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
7.4.12. Rest of LATAM Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Point Of Care Diagnostics Market Outlook, 2020-2033
8.1. Middle East & Africa Point Of Care Diagnostics Market Outlook, by Product, Value (US$ Bn), 2020-2033
8.1.1. Blood Glucose Monitoring
8.1.2. Infectious Disease Testing
8.1.3. Cardiometabolic Disease Testing
8.1.4. Pregnancy & Fertility Testing
8.1.5. Hematology Testing
8.1.6. Others
8.2. Middle East & Africa Point Of Care Diagnostics Market Outlook, by Sample, Value (US$ Bn), 2020-2033
8.2.1. Blood
8.2.2. Nasal and Oropharyngeal Swabs
8.2.3. Urine
8.2.4. Others
8.3. Middle East & Africa Point Of Care Diagnostics Market Outlook, by End-User, Value (US$ Bn), 2020-2033
8.3.1. Hospital Bedside
8.3.2. Physician’s Office Lab
8.3.3. Urgent Care & Retail Clinics
8.3.4. Home & Self Testing
8.4. Middle East & Africa Point Of Care Diagnostics Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
8.4.2. GCC Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
8.4.3. GCC Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
8.4.4. South Africa Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
8.4.5. South Africa Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
8.4.6. South Africa Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
8.4.7. Egypt Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
8.4.8. Egypt Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
8.4.9. Egypt Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
8.4.10. Nigeria Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
8.4.11. Nigeria Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
8.4.12. Nigeria Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
8.4.13. Rest of Middle East Point Of Care Diagnostics Market Outlook, by Product, 2020-2033
8.4.14. Rest of Middle East Point Of Care Diagnostics Market Outlook, by Sample, 2020-2033
8.4.15. Rest of Middle East Point Of Care Diagnostics Market Outlook, by End-User, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Abbott Laboratories
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Roche Diagnostics
9.4.3. Siemens Healthineers
9.4.4. Danaher Corporation (including Beckman Coulter & Cepheid)
9.4.5. Thermo Fisher Scientific
9.4.6. QuidelOrtho Corporation
9.4.7. Becton, Dickinson and Company (BD)
9.4.8. bioMérieux
9.4.9. Hologic, Inc.
9.4.10. Nova Biomedical
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations